MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 ...

A medicine the pharma acquired in a $430 million buyout of Visterra in 2018 succeeded in a Phase 3 trial in IgA nephropathy, a crowded corner of drug research.

Enzymes help speed up chemical reactions in the body. They control everything from digesting food, to muscle growth, to blood ...

Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent ...

TreeHouse Foods issued a voluntary recall last week for its frozen waffle products that are sold at many retailers in the U.S ...

This fall, the federal government is offering a new round of free COVID-19 tests, but many of the tests arriving in mailboxes ...